Log In
BCIQ
Print this Print this
 

IN Diazepam

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionIntranasal formulation of diazepam
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationEpilepsy
Indication DetailsTreat acute, repetitive seizures associated with epilepsy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$394.4M

$394.4M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/06/2014

$394.4M

$394.4M

0

Get a free BioCentury trial today